MedPage Today on MSN
Among IL-1 Inhibitors for Treating VEXAS, This One Stands Out
Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome ...
In preclinical models, rat insulinoma‑derived beta‑cell line INS‑1 (INS‑1) cells and mouse islets showed rapid, robust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback